Serum Potassium as a Predictor of Clinical Outcomes in an Older Patient Cohort With Chronic Postsurgical Pain
1 other identifier
observational
3,088
1 country
1
Brief Summary
Perioperative serum potassium in patients over 65 impacts recovery, quality of life and physical functioning. While perioperative serum potassium is an important preoperative risk factor for poor surgical outcomes in older adults, the relationship between perioperative serum potassium and postsurgical pain in this population has not been investigated. The investigators hypothesized that preoperative serum potassium would be associated with greater odds of postsurgical chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedFirst Submitted
Initial submission to the registry
May 15, 2022
CompletedFirst Posted
Study publicly available on registry
May 23, 2022
CompletedMay 26, 2022
May 1, 2022
2.1 years
May 15, 2022
May 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain trajectories after surgery (Numerical Rating Scale)
Pain intensity was assessed using a numerical rating scale (NRS) from 0 to 10, with zero representing no pain and 10 representing worst imaginable pain. The worst pain intensity was then categorized into two groups: no or mild pain (NRS from 0 to 3) and moderate to severe pain (NRS from 4 to 10).
Up to 3 months postoperation
The Brief Pain Inventory-short form
It measured pain location in the body; pain intensity on an 11-point numerical rating scale (NRS; 0 represents "no pain" and 10 the "worst pain imaginable"); analgesic intake; perception of analgesic relief; and pain interference with daily life on an 11-point NRS (0 "does not interfere and 10"completely interferes") indistinct dimensions (general activity, mood, walking, work, relations with others, sleep, and enjoyment of life). Higher scores represent higher levels of pain interference.
Up to 3 months postoperation
Secondary Outcomes (3)
Pain Catastrophizing Scale (PCS)
within 30 days prior to surgery ,Up to 3 months postoperation
The trajectories of health related quality of life(HRQoL)
within 30 days prior to surgery , 1, 3, 7, 30, 90 days postoperation
The Frail Scale
within 30 days prior to surgery ,Up to 3 months postoperation
Study Arms (2)
CPSP group
Patients who developed chronic pain 3 months after surgery
UN-CPSP group
Patients who did not develop chronic pain 3 months after surgery
Interventions
Eligibility Criteria
hospital based group
You may qualify if:
- Geriatric surgical patients ≥65 years old
- Diagnosis of Chronic postsurgical pain (CPSP) CPSP was made based on the guidelines of the International Society for Pain (CPSP: ICD-11) as follows: Chronic postsurgical pain is chronic pain developing or increasing in intensity after a surgical procedure and persisting beyond the healing process, i.e. at least 3 months after surgery. The pain is either localised to the surgical field, projected to the innervation territory of a nerve situated in this area, or referred to a dermatome (after surgery/injury to deep somatic or visceral tissues). Other causes of pain including infection, malignancy etc. need to be excluded as well as pain continuing from a pre-existing pain problem. Dependent on type of surgery, chronic postsurgical pain often may be neuropathic pain.
You may not qualify if:
- Patients in the central nervous system group were excluded from cardiac and neurosurgery, patients in the heart injury group were excluded from cardiac surgery.
- patients who did not agree to participate in the study were excluded in all groups.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chinese PLA General Hospitallead
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoolcollaborator
- First Affiliated Hospital of Guangxi Medical Universitycollaborator
- Sun Yat-sen Universitycollaborator
- The Affiliated Hospital Of Guizhou Medical Universitycollaborator
- Peking University People's Hospitalcollaborator
- China-Japan Friendship Hospitalcollaborator
- Fudan Universitycollaborator
Study Sites (1)
Chinese PLA General Hospital
Beijing, Beijing, Beijing, China, 100853, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mi Weidong, PhD
Chinese PLA General Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Chief of administration, Anesthesiology
Study Record Dates
First Submitted
May 15, 2022
First Posted
May 23, 2022
Study Start
April 1, 2020
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
May 26, 2022
Record last verified: 2022-05